Personal information

Emails & domains

Verified email domains

Websites & social links

Rutgers homepage
Lab page
@Mybibiolography of NCBI
@Google Scholar
@Research Gate

Other IDs

ResearcherID: D-1544-2009

Keywords

Biomarkers, Computational biology, Machine learning, Cancer, Clinical epidemiology, Genomic medicine, Public health interventions, COVID-19, Breast cancer, Colorectal tumors, Health disparity, Liver diseases / Hepatology

Countries

United States

Biography

I am currently interested in clinical epidemiology, statistical methodology and machine learning concerning cancers and other chronic diseases. My work at Michigan was focused on normal pancreatic stem cell and pancreatic cancer initiating cells. During my residency at Mount Sinai School of Medicine, and gastrointestinal and liver pathology fellowship at UPenn, my primary clinical and research interest was the diagnostics of gastrointestinal and liver diseases.

Activities

Collapse all

Employment (10)

Princeton Medical Center: Plainsboro, NJ, US

2023 to present | Chair (Department of Pathology and Lab Medicine)
Employment
Source: Self-asserted source
Lanjing Zhang

Rutgers University Ernest Mario School of Pharmacy: Piscataway, NJ, US

2022 to present | Research Professor (Dept of Chemical Biology)
Employment
Source: Self-asserted source
Lanjing Zhang

Rutgers Cancer Institute of New Jersey: New Brunswick, NJ, US

2022 to present | Full Member
Employment
Source: Self-asserted source
Lanjing Zhang

Rutgers University Ernest Mario School of Pharmacy: Piscataway, NJ, US

2014 to present | Adjunct Professor (Chemical Biology)
Employment
Source: Self-asserted source
Lanjing Zhang

Princeton Medical Center: Plainsboro, NJ, US

2011 to present | Director, GI and Liver Pathology (Department of Pathology)
Employment
Source: Self-asserted source
Lanjing Zhang

University of Pennsylvania: PA, PA, US

2022-07 to 2027-06 | Adjunct Professor (Dept. of Pathology and Lab Medicine)
Employment
Source: Self-asserted source
Lanjing Zhang

Princeton Medical Center: Plainsboro, NJ, US

2019 to 2023 | Vice Chair (Department of Pathology and Lab Medicine)
Employment
Source: Self-asserted source
Lanjing Zhang

Rutgers Cancer Institute of New Jersey: New Brunswick, NJ, US

2013 to 2022 | Associate Member
Employment
Source: Self-asserted source
Lanjing Zhang

Rutgers University Newark: Newark, NJ, US

2016 to 2021 | Visiting Professor (Biological Sciences)
Employment
Source: Self-asserted source
Lanjing Zhang

Rutgers Robert Wood Johnson Medical School: Piscataway, NJ, US

2012 to 2016 | Clinical Assistant Professor (Department of Pathology)
Employment
Source: Self-asserted source
Lanjing Zhang

Education and qualifications (4)

Hospital of the University of Pennsylvania: Philadelphia, PA, US

2010 to 2011 | GI and Liver Pathology Fellow (Pathology)
Education
Source: Self-asserted source
Lanjing Zhang

Mount Sinai Hospital: New York, NY, US

2006 to 2010 | Resident (Pathology)
Education
Source: Self-asserted source
Lanjing Zhang

University of Michigan Medical School: Ann Arbor, MI, US

2000 to 2006 | Postdoc Fellow
Education
Source: Self-asserted source
Lanjing Zhang

Huazhong University of Science and Technology Tongji Medical College: Wuhan, Hubei, CN

1993 to 2000 | M.D., M.S.
Education
Source: Self-asserted source
Lanjing Zhang

Professional activities (2)

National Institutes of Health: Md., Md., US

2019 to present | Grant Reviewer
Service
Source: Self-asserted source
Lanjing Zhang

National Science Foundation: VA, VA, US

2021 to 2023 | Grant reviewer
Service
Source: Self-asserted source
Lanjing Zhang

Funding (10)

SCH:Screeningandconfirmatorymachinelearningforexplainablemodelingofnon-cancerdeathsincancerpatients

2022-09 to 2026-08 | Award
National Cancer Institute (Bethesda, US)
GRANT_NUMBER:

R37CA277812-01
Source: Self-asserted source
Lanjing Zhang

EAGER: Integration and analysis of high-dimensional dataset (PI: Zhang)

2021-10 to 2024-09 | Grant
National Science Foundation (VA, VA, US)
GRANT_NUMBER:

IIS-2128307

Source: Self-asserted source
Lanjing Zhang

Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer (Consultant, Zhang; PI, Hu)

2021-04 to 2026-03 | Grant
National Cancer Institute (Md., Md., US)
GRANT_NUMBER:

R01CA176647
Source: Self-asserted source
Lanjing Zhang

Epigenetically Engineered Mouse Model for Lung Cancer Therapy (Co-I: Zhang, PI: Shen)

2021 to 2026 | Grant
National Cancer Institute (Md., Md., US)
GRANT_NUMBER:

R01CA261723

Source: Self-asserted source
Lanjing Zhang

Ramzi S. Cotran Young Investigator Award (PI: Zhang)

2021 to 2024 | Award
US and Canadian Academy of Pathology (Palm Spring, CA, USA, US)
Source: Self-asserted source
Lanjing Zhang

State heterogeneity of COVID-19 epidemics in the European Union (PI, Zhang; Hu as the first author)

2020-06 to 2020-12 | Award
Chinese American Pathologists Association (Boston, MA, US)
Source: Self-asserted source
Lanjing Zhang

Lysozyme controls mucosal immune response to microbiota (Co-I, Zhang; PI, Gao)

2019 to 2024 | Grant
National Institute of Diabetes and Digestive and Kidney Diseases (Md., Md., US)
Source: Self-asserted source
Lanjing Zhang

IL11 promotes dietary carcinogen-induced colon carcinogenesis (Co-I, Zhang; PI, Wang)

2018-01 to 2018-12 | Grant
Rutgers Cancer Institute of New Jersey (NJ, NJ, US)
Source: Self-asserted source
Lanjing Zhang

Synergistic Exploration of Paneth Cell Plasticity in Epithelial Pathogenesis (Co-PI, Zhang; PI, Gao)

2015-07 to 2017-06 | Grant
Rutgers University (Newark, NJ, US)
Source: Self-asserted source
Lanjing Zhang

Subspecialty Resident Grant for Gastrointestinal and Liver Pathology (PI, Zhang)

2009 to 2009 | Grant
American Society for Clinical Pathology (IL, IL, US)
Source: Self-asserted source
Lanjing Zhang
How many people are using ORCID?